Preclinical studies in animal models have demonstrated that GLP-1 receptor activation may reduce amyloid-beta accumulation, decrease tau phosphorylation, and protect neurons from oxidative damage
Litigation UK health authorities have initiated an investigation into potential links between GLP-1 receptor agonistsincluding Ozempic (semaglutide), Wegovy (semaglutide), and Mounjaro (tirzepatide)and reported cases of pancreatitis
Most online GLP-1 programs cannot make this claim
Through a collaborative approach involving patient education, dietary management, and careful monitoring, healthcare providers can help patients navigate these side effects, ensuring that the advantages of Semaglutide are fully realized
While cholesterol reduction was not the primary endpoint, the overall cardiovascular benefit reflects improvements in multiple risk factors, including lipid panels, blood pressure, and inflammation markers